Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 222

1.
2.

Sodium stibogluconate and paromomycin for treating visceral leishmaniasis under routine conditions in eastern Sudan.

Atia AM, Mumina A, Tayler-Smith K, Boulle P, Alcoba G, Elhag MS, Alnour M, Shah S, Chappuis F, van Griensven J, Zachariah R.

Trop Med Int Health. 2015 Dec;20(12):1674-84. doi: 10.1111/tmi.12603. Epub 2015 Nov 11.

4.

Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial.

Musa A, Khalil E, Hailu A, Olobo J, Balasegaram M, Omollo R, Edwards T, Rashid J, Mbui J, Musa B, Abuzaid AA, Ahmed O, Fadlalla A, El-Hassan A, Mueller M, Mucee G, Njoroge S, Manduku V, Mutuma G, Apadet L, Lodenyo H, Mutea D, Kirigi G, Yifru S, Mengistu G, Hurissa Z, Hailu W, Weldegebreal T, Tafes H, Mekonnen Y, Makonnen E, Ndegwa S, Sagaki P, Kimutai R, Kesusu J, Owiti R, Ellis S, Wasunna M.

PLoS Negl Trop Dis. 2012;6(6):e1674. doi: 10.1371/journal.pntd.0001674. Epub 2012 Jun 19.

5.

Visceral leishmaniasis relapse in Southern Sudan (1999-2007): a retrospective study of risk factors and trends.

Gorski S, Collin SM, Ritmeijer K, Keus K, Gatluak F, Mueller M, Davidson RN.

PLoS Negl Trop Dis. 2010 Jun 8;4(6):e705. doi: 10.1371/journal.pntd.0000705.

6.

Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme.

Kimutai R, Musa AM, Njoroge S, Omollo R, Alves F, Hailu A, Khalil EA, Diro E, Soipei P, Musa B, Salman K, Ritmeijer K, Chappuis F, Rashid J, Mohammed R, Jameneh A, Makonnen E, Olobo J, Okello L, Sagaki P, Strub N, Ellis S, Alvar J, Balasegaram M, Alirol E, Wasunna M.

Clin Drug Investig. 2017 Mar;37(3):259-272. doi: 10.1007/s40261-016-0481-0.

7.

Immunochemotherapy of persistent post-kala-azar dermal leishmaniasis: a novel approach to treatment.

Musa AM, Khalil EA, Mahgoub FA, Elgawi SH, Modabber F, Elkadaru AE, Aboud MH, Noazin S, Ghalib HW, El-Hassan AM; Leishmaniasis Research Group/Sudan..

Trans R Soc Trop Med Hyg. 2008 Jan;102(1):58-63. Epub 2007 Oct 25.

PMID:
17963805
9.

Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan.

Collin S, Davidson R, Ritmeijer K, Keus K, Melaku Y, Kipngetich S, Davies C.

Clin Infect Dis. 2004 Mar 1;38(5):612-9. Epub 2004 Feb 12.

PMID:
14986243
10.

Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.

Moore E, O'Flaherty D, Heuvelmans H, Seaman J, Veeken H, de Wit S, Davidson RN.

Bull World Health Organ. 2001;79(5):388-93.

12.
13.
14.

Aminosidine plus sodium stibogluconate for the treatment of Indian kala-azar: a randomized dose-finding clinical trial.

Thakur CP, Bhowmick S, Dolfi L, Olliaro P.

Trans R Soc Trop Med Hyg. 1995 Mar-Apr;89(2):219-23.

PMID:
7778155
15.
16.

A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan.

Mueller M, Balasegaram M, Koummuki Y, Ritmeijer K, Santana MR, Davidson R.

J Antimicrob Chemother. 2006 Oct;58(4):811-5. Epub 2006 Aug 17.

PMID:
16916865
17.

A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection.

Ritmeijer K, Dejenie A, Assefa Y, Hundie TB, Mesure J, Boots G, den Boer M, Davidson RN.

Clin Infect Dis. 2006 Aug 1;43(3):357-64. Epub 2006 Jun 20.

PMID:
16804852
18.

Combination therapy in Kala-azar.

Singh NK, Jha TK, Singh IJ, Jha S.

J Assoc Physicians India. 1995 May;43(5):319-20.

PMID:
9081958
19.

Post-kala-azar dermal leishmaniasis in the Sudan: clinical presentation and differential diagnosis.

Zijlstra EE, Khalil EA, Kager PA, El-Hassan AM.

Br J Dermatol. 2000 Jul;143(1):136-43.

PMID:
10886148
20.

A thirty day course of sodium stibogluconate for treatment of Kala-azar in Nepal.

Karki P, Koirala S, Parija SC, Hansdak SG, Das ML.

Southeast Asian J Trop Med Public Health. 1998 Mar;29(1):154-8.

PMID:
9740292

Supplemental Content

Support Center